Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06080503 · ClinicalTrials.gov registry record · NA
Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
A NA study of Laryngeal Carcinoma, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 1
- Study location
NCT06080503: Recruiting NA study of Laryngeal Carcinoma, sponsored by University of Texas Southwestern Medical Center.
NCT06080503 is a NA study of Laryngeal Carcinoma that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06080503, a NA study of Laryngeal Carcinoma, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.
Primary Outcome
Acute toxicity score (i.e. T score), defined as the mean number of grade 2 or higher acute toxicities experienced between the start of radiotherapy and 3 months following treatment.
Conditions Studied
Interventions
- RADIATION LT-SABR
- RADIATION IMRT
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-03-14 |
| Est. Completion | 2029-03-14 |
| Phase | NA |
What NCT06080503 shows while recruiting
NCT06080503 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Laryngeal Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which LT-SABR is the first listed.
NCT06080503 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06080503 about?
NCT06080503 is a clinical study titled "Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy". To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.
What is the current status of trial NCT06080503?
This trial is currently recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2024-03-14. Estimated completion is 2029-03-14.
What conditions does trial NCT06080503 study?
This clinical trial studies the following conditions: Laryngeal Carcinoma.
What interventions are being tested in trial NCT06080503?
The interventions under investigation include: LT-SABR (RADIATION), IMRT (RADIATION).
Who is sponsoring clinical trial NCT06080503?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06080503 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Laryngeal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06080503's enrollment target sits among peer trials
67 1139th of 2000 higher than 862 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment
COMPLETED · NA
-
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI